Vinblastine Sulfate: The Vinca Alkaloid Powerhouse in Most cancers Therapeutics | Supplier & Manufacturer
1. What is Vinblastine?
Vinblastine sulfate is a dimeric indole-dihydroindole vinca alkaloid derived from the Madagascar periwinkle (Catharanthus roseus). As a potent microtubule-destabilizing agent, it binds to β-tubulin subunits on the vinca area, inhibiting microtubule meeting and suppressing mitotic spindle formation. This triggers G2/M part arrest و mitotic disaster in quickly proliferating cells. Acknowledged as an important drugs by WHO, it is clinically indispensable for treating Hodgkin lymphoma, testicular most cancers, and superior breast carcinoma.
2. Supply, Chemical Properties & Identifiers
-
إمداد: Remoted from leaves of Catharanthus roseus; semi-synthesis from precursors catharanthine and vindoline.
-
الخصائص الكيميائية:
-
الاسم الكيميائي: Methyl (3aR,4R,5S,5aR,10bR,13aR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,4,5,5a,6,11,12,13a-octahydro-1H-indolizino(8,1-cd)carbazole-5-carboxylate sulfate
-
Molecular Formulation: C₄₆H₅₈N₄O₉ · H₂SO₄
-
الوزن الجزيئي: 909.06 g/mol
-
مظهر: White to off-white hygroscopic crystalline powder
-
الذوبان: Freely soluble in water, methanol; insoluble in ether
-
استقرار: Mild-sensitive; oxidizes beneath alkaline situations
-
-
معرفات رئيسية:
-
كاس: 143-67-9 (vinblastine sulfate)
-
كمية EC (EINECS): 205-620-3
-
م ف: C₄₆H₆₀N₄O₁₃S
-
م و: 909.06
-
3. Pharmaceutical-Grade High quality & Scientific Profile
-
Optimum Product: Requires >99.5% HPLC purity, <0.1% vincristine (poisonous isomer), and undetectable endotoxins (<0.25 EU/mg). Shaanxi Zhonghong ensures this by way of countercurrent chromatography و crystallization controls.
-
Therapeutic Purposes:
-
Oncology: First-line for Hodgkin’s lymphoma (ABVD routine), NSGCT, choriocarcinoma, Kaposi sarcoma.
-
الآلية: Binds tubulin → depolymerizes microtubules → blocks metaphase → apoptosis.
-
(Be aware: Nattokinase reveals anticoagulant properties; no strong proof helps kidney-specific advantages)
-
-
الجرعة:
-
Medical Use Solely: Administered IV (0.1-0.5 mg/kg weekly). No oral complement kind exists.
-
-
Vital Security Profile:
-
Hematologic: Extreme neutropenia (nadir Day 7-10), thrombocytopenia.
-
Neurotoxicity: Peripheral neuropathy (much less extreme than vincristine).
-
GI Results: Nausea, constipation, ileus.
-
Extravasation Hazard: Causes tissue necrosis; requires central line administration.
-
موانع الاستعمال: Energetic infections, bone marrow suppression, being pregnant (FDA Class D).
-
4. Shaanxi Zhonghong: Pioneering Vinca Alkaloid Manufacturing
With 28+ years in plant-derived oncology APIs, we ship cGMP vinblastine sulfate assembly USP/EP monographs. Core strengths:
-
Scientific Infrastructure:
-
5 Tutorial Joint Labs (Isolation chemistry, analytical improvement)
-
Patented Extraction Tech (CN202310XXXXXX: high-yield vindoline purification)
-
-
Analytical Superiority:
-
HPLC-ELSD/MS (purity)
-
UPLC-PDA (isomeric impurity management)
-
Superconducting 600MHz NMR (structural affirmation)
-
LAL Endotoxin Testing (<0.25 EU/mg)
-
-
World Provide: APIs shipped to 80+ international locations beneath cold-chain protocols.
5. Rigorous High quality Specs
فصل | المعلمة | مواصفة | Technique |
---|---|---|---|
المبيدات الحشرية | ديكلوروفوس | ≤0.01 mg/kg | GC-MS/MS (EU 2021/601) |
الملاثيون | ≤0.05 mg/kg | كروماتوغرافيا الغاز-مطياف الكتلة/مطياف الكتلة | |
المعادن الثقيلة | الرصاص | ≤1 ppm | ICP-MS (USP <232>) |
مثل | ≤0.5 جزء في المليون | ICP-MS | |
علم الأحياء الدقيقة | مركز تامك | ≤10² CFU/g | جامعة ساو باولو <61> |
Bile-tolerant GNR | غائب/10 جرام | جامعة ساو باولو <62> | |
Vital Attributes | Vinblastine Sulfate | ≥99.5% | HPLC-ELSD (USP <621>) |
فينكريستين | ≤0.1% | UPLC-PDA | |
محتوى الماء | ≤5.0% | Karl Fischer | |
السموم الداخلية | <0.25 EU/mg | LAL (USP <85>) |
6. cGMP Manufacturing Course of
-
Biomass Cultivation: C. roseus grown beneath GACP-controlled situations.
-
Alkaloid Extraction: pH-modulated solvent extraction (EtOAc/H₂O).
-
Chromatographic Separation: Flash chromatography → HPLC purification (vindoline/catharanthine).
-
Dimerization: Fe³⁺-catalyzed coupling of vindoline and catharanthine.
-
Sulfation: Response with sulfur trioxide advanced.
-
بلورة: Managed anti-solvent addition for crystal polymorphism administration.
-
التجميد بالتجميد: Freeze-drying beneath argon ambiance.
7. Scientific & Analysis Purposes
-
Oncology: Core part of:
-
ABVD (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine)
-
VEBEP (Vinblastine, Etoposide, Bleomycin, Cisplatin)
-
-
Drug Supply Improvements:
-
Liposomal encapsulation (lowered neurotoxicity)
-
Antibody-drug conjugates (anti-CD30-VLA complexes)
-
-
Cell Biology: Device compound for mitotic inhibition research.
8. cGMP High quality Management Protocol
Our 360° QC technique contains:
-
Id: الرنين المغناطيسي النووي ¹H/¹³C spectral match (δ 0.98 ppm, 3H, t; δ 3.70 ppm, 3H, s).
-
نقاء: RP-HPLC-ELSD (Luna C18, 0.1% TFA/MeCN gradient) quantifies vinblastine (≥99.5%), vincristine (≤0.1%).
-
Efficiency: Cell-based mitotic arrest assay (HeLa cells, EC₅₀ ≤2 nM).
-
Security: Bacterial endotoxins (LAL kinetic chromogenic), sterility (membrane filtration USP <71>), residual solvents (GC-HS).
-
استقرار: 36-month shelf-life at 2-8°C (validated per ICH Q1A(R2)).
9. Chilly-Chain Logistics
-
Major Pack: Sort I glass vials (nitrogen headspace) with fluoropolymer-coated stoppers.
-
الحزمة الثانوية: Vacuum-sealed Alu-bags في UN-certified shippers with temperature loggers.
-
تخزين: 2-8°C protected against gentle; desiccant included.
-
Transport: World cold-chain transport (2-8°C) by way of DHL LifeConEx.
10. Mechanism & Innovation
-
Molecular Motion: Binds β-tubulin vinca website → tubulin dissociation fixed (Kd=6.8 μM) → suppressed GTP hydrolysis → microtubule fragmentation.
-
Zhonghong Improvements:
-
PAT-enabled crystallization (Patent CN202210XXXXXX)
-
Enzymatic dimerization (yield ↑40%)
-
-
حدود التحليل:
-
Oral formulations (P-glycoprotein inhibitors)
-
Tubulin isotype-selective analogs (βIII-tubulin concentrating on)
-
-
التحديات: Myelosuppression, neuropathy, chemoresistance (ABCB1 overexpression).
11. الأسئلة الشائعة
Q1: Can vinblastine be used as a dietary complement?
A: Completely not. Vinblastine is a cytotoxic chemotherapy agent requiring medical supervision. Self-administration is life-threatening.
Q2: How does nattokinase examine for kidney well being?
A: Nattokinase lacks scientific proof for nephroprotection. Vinblastine might trigger nephrotoxicity at excessive doses. Neither compound is indicated for renal situations.
Q3: Why is vincristine impurity management crucial?
*A: Vincristine causes extreme neurotoxicity at microgram doses. Our UPLC-PDA methodology detects ≤0.01% impurity.*
This autumn: What distinguishes Zhonghong’s vinblastine?
*A: cGMP manufacturing, 99.5%+ HPLC purity, endotoxin management (<0.25 EU/mg), and patented crystallization expertise guaranteeing polymorph stability.*
Q5: Do you provide vinblastine for ADC improvement?
A: Sure. GMP-grade linker-conjugated vinblastine (maleimide-PEG₃-vinblastine) accessible for antibody-drug conjugates.
12. World Sourcing
Procure cGMP vinblastine sulfate:
✉️ بريد إلكتروني: liaodaohai@gmail.com
🌐 شبكة: www.aiherba.com
Request: COA, DMF, CEP, and customized synthesis quotations.
13. الخاتمة
Vinblastine sulfate stays a cornerstone antineoplastic agent with irreplaceable scientific worth. Its efficacy hinges on ultra-high purity (>99.5%), stringent impurity management (vincristine ≤0.1%)، و temperature-controlled dealing with. Shaanxi Zhonghong combines 28 years of vinca alkaloid experience, patented purification expertise، و الامتثال لممارسات التصنيع الجيدة الحالية (cGMP) to ship oncology APIs that meet world pharmacopeial requirements. Associate with us for uncompromising high quality in most cancers therapeutics.
14. المراجع
-
Noble RL, et al. (1958). مجلة الكيمياء الأمريكية. 80:3487. [DOI:10.1021/ja01546a092]
-
Jordan MA, et al. (2002). Mol Most cancers Ther. 1:935–943. [PMID:12481413]
-
WHO Mannequin Record of Important Medicines (2023). Vinblastine sulfate injection.
-
USP Monograph: Vinblastine Sulfate. USP44-NF39.
-
EMA Guideline: Specs for cytotoxic APIs (CPMP/QWP/1850/04)
-
Dumontet C, et al. (2020). Nat Rev Drug Discov. 19:585–608. [DOI:10.1038/s41573-020-0072-8]
-
Zhonghong Patent: CN202310XXXXXX (Vinblastine crystallization management)
-
ICH Q3D (R2): Elemental Impurities (2022)
-
FDA Steerage: Vinblastine Label (NSC-49842)
-
Gidding CEM, et al. (1999). Most cancers Chemother Pharmacol. 44:266–272. [DOI:10.1007/s002800050976]
المراجعات
لا توجد مراجعات بعد.